Cite
Pharmacokinetics of zidovudine (azidothymidine). II. Development of metabolic and renal clearance pathways in the neonate
MLA
Lopez-Anaya, Arturo, et al. “Pharmacokinetics of Zidovudine (Azidothymidine). II. Development of Metabolic and Renal Clearance Pathways in the Neonate.” Journal of Acquired Immune Deficiency Syndromes, vol. 3, no. 11, Nov. 1990, p. 1052. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.9172002&authtype=sso&custid=ns315887.
APA
Lopez-Anaya, A., Unadkat, J. D., Schumann, L. A., & Smith, A. L. (1990, November 1). Pharmacokinetics of zidovudine (azidothymidine). II. Development of metabolic and renal clearance pathways in the neonate. Journal of Acquired Immune Deficiency Syndromes, 3(11), 1052.
Chicago
Lopez-Anaya, Arturo, Jashvant D. Unadkat, Louise A. Schumann, and Arnold L. Smith. 1990. “Pharmacokinetics of Zidovudine (Azidothymidine). II. Development of Metabolic and Renal Clearance Pathways in the Neonate.” Journal of Acquired Immune Deficiency Syndromes, November 1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.9172002&authtype=sso&custid=ns315887.